BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8459060)

  • 41. Effects of A1 adenosine receptor blockade on the warm-up phenomenon.
    Tomai F; Crea F; Danesi A; Perino M; Gaspardone A; Ghini AS; Ruggeri G; Chiariello L; Gioffrè PA
    Cardiologia; 1997 Apr; 42(4):385-92. PubMed ID: 9188207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased exercise tolerance and reduced electrocardiographic ischemia with diltiazem in patients with stable angina pectoris.
    Wagniart P; Ferguson RJ; Chaitman BR; Achard F; Benacerraf A; Delanguenhagen B; Morin B; Pasternac A; Bourassa MG
    Circulation; 1982 Jul; 66(1):23-8. PubMed ID: 7083512
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased blood pressure and neural tone in the silent ischemia of hypertension: disparate effects of immediate release nifedipine.
    Lee DD; Rigonan K; Dequattro V
    J Am Coll Cardiol; 1993 Nov; 22(5):1438-45. PubMed ID: 8227803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of mibefradil compared with amlodipine in suppressing exercise-induced and daily silent ischemia: results of a multicenter, placebo-controlled trial.
    Tzivoni D; Kadr H; Braat S; Rutsch W; Ramires JA; Kobrin I
    Circulation; 1997 Oct; 96(8):2557-64. PubMed ID: 9355894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of myocardial ischemia on the ergocycle versus the treadmill in patients with coronary heart disease.
    Noël M; Jobin J; Marcoux A; Poirier P; Dagenais G; Bogaty P
    Am J Cardiol; 2010 Mar; 105(5):633-9. PubMed ID: 20185009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of a new calcium antagonist, mibefradil (Ro 40-5967), on silent ischemia in patients with stable chronic angina pectoris: a multicenter placebo-controlled study. The Mibefradil International Study Group.
    Braun S; van der Wall EE; Emanuelsson H; Kobrin I
    J Am Coll Cardiol; 1996 Feb; 27(2):317-22. PubMed ID: 8557900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of adenosine and opioid-receptor mechanisms for pain in patients with silent myocardial ischemia or angina pectoris: a double-blind, placebo-controlled study.
    Sadigh-Lindell B; Sylvén C; Berglund M; Eriksson BE
    J Cardiovasc Pharmacol; 2003 Dec; 42(6):757-63. PubMed ID: 14639098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of nifedipine on myocardial perfusion during exercise in chronic stable angina pectoris.
    Rice KR; Gervino E; Jarisch WR; Stone PH
    Am J Cardiol; 1990 May; 65(16):1097-101. PubMed ID: 2184649
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gallopamil in chronic stable angina: antianginal effect and mechanism of action. A randomized, placebo-controlled, double-blind, cross-over trial.
    Zanolla L; Carbonieri E; Rossi L; Marino P; Zardini P
    Cardiology; 1992; 80(5-6):324-31. PubMed ID: 1451119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS).
    Andrews TC; Fenton T; Toyosaki N; Glasser SP; Young PM; MacCallum G; Gibson RS; Shook TL; Stone PH
    Circulation; 1993 Jul; 88(1):92-100. PubMed ID: 8319361
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced glucose oxidation in exercise-induced myocardial ischemia.
    Montague T; DeAlmeida J; Lopaschuk G; Witkowski F; Walker D; Ackman M; Humen D; Dzavik V; Teo K
    Can J Cardiol; 1994 Nov; 10(9):913-9. PubMed ID: 7954027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiischemic effects of intravenous diazepam in patients with coronary artery disease.
    Rossetti E; Fragasso G; Xuereb RG; Xuereb M; Margonato A; Chierchia SL
    J Cardiovasc Pharmacol; 1994 Jul; 24(1):55-8. PubMed ID: 7521490
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
    Thadani U; Ezekowitz M; Fenney L; Chiang YK
    Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is 'silent' myocardial ischemia really as severe as symptomatic ischemia? The analytical effect of patient selection biases.
    Klein J; Chao SY; Berman DS; Rozanski A
    Circulation; 1994 May; 89(5):1958-66. PubMed ID: 8181118
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Asymptomatic Cardiac Ischemia Pilot (ACIP) study: impact of anti-ischemia therapy on 12-week rest electrocardiogram and exercise test outcomes. The ACIP Investigators.
    Chaitman BR; Stone PH; Knatterud GL; Forman SA; Sopko G; Bourassa MG; Pratt C; Rogers WJ; Pepine CJ; Conti CR
    J Am Coll Cardiol; 1995 Sep; 26(3):585-93. PubMed ID: 7642847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Relationship between ischemic ST depression and oxygen uptake kinetics during ramp exercise test in patients with effort angina].
    Yokoyama Y; Tanabe K; Yamamoto A; Oya M; Murabayashi T; Suzuki N; Nakayama M; Osada N; Yamamoto M; Omiya K; Itoh H; Murayama M
    J Cardiol; 1996 May; 27(5):241-6. PubMed ID: 8642511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of dipyridamole therapy on myocardial ischemia in patients with stable angina pectoris receiving concurrent anti-ischemic therapy.
    Barbour MM; Garber CE; Agarwal KC; Malhotra R; Heller GV
    Am J Cardiol; 1992 Feb; 69(5):449-52. PubMed ID: 1736604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigation of therapeutic mechanisms of atenolol and diltiazem in patients with variable-threshold angina.
    Nadazdin A; Davies GJ
    Am Heart J; 1994 Feb; 127(2):312-7. PubMed ID: 8296698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris. The Angina and Silent Ischemia Study Group (ASIS).
    Borzak S; Fenton T; Glasser SP; Shook TL; MacCallum G; Young PM; Stone PH
    J Am Coll Cardiol; 1993 Jun; 21(7):1605-11. PubMed ID: 8496526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of hepatocyte growth-promoting factors on myocardial ischemia during exercise in patients with severe coronary artery disease.
    Wang N; Tong G; Yang J; Zhou Z; Pan H; Huo Y; Xu J; Zhang X; Ling F; Li P
    Int Heart J; 2009 May; 50(3):291-9. PubMed ID: 19506333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.